Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
Lindsay M. Morton(National Cancer Institute), Rochelle E. Curtis(National Institutes of Health), Clara J. Kim(National Institutes of Health), Graça M. Dores(United States Food and Drug Administration), Margaret A. Tucker(National Cancer Institute), Kenan Onel(Icahn School of Medicine at Mount Sinai), Joseph F. Fraumeni(National Institutes of Health), Ethel S. Gilbert(National Institutes of Health)
Cited by 235
Related Papers
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
Replicating genotype–phenotype associations
|Nature|2007|1.4k
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k